Adverse reactions: Next steps in learning...
Here are some resources to help extend your knowledge about adverse reactions and advising about their prevention and management in clinical practice:
NHS Education for Scotland and the Yellow Card Centre of Scotland have jointly produced a range of e-learning modules on adverse drug reactions. If you didn't manage to work your way through all of these earlier in the tutorial then you may like to tackle them now.
Try the e-learning module on pharmacovigilance developed by SCOPE (Strengthening Collaboration for Operating Pharmacovigilance in Europe) which was developed with approval of the MHRA.
Via CPPE you can access a series of three Adverse drug reactions e-learning
programmes developed by the Welsh Centre for Pharmacy Professional Education (WCPPE). You can choose
the one you want from here, or use the links below:
The CPPE Medicines Safety app: the quizzes on adverse drug reactions and allergies are particularly relevant to this clinical topic.- Adverse drug reactions and medicines safety focuses on identifying different types of adverse drug reactions.
- Reporting adverse drug reactions describes how and when to report reactions.
- Patients and adverse drug reactions focuses on patients at risk of adverse drug reactions and preventing them.
On the Medicines Learning Portal, there are other tutorials with a connection to ADRs and safety, including Excipients, Renal, Liver, and Alternative medicine. You might like to study these.
Finally, you may like to review two additional sources of information about adverse drug reactions that offer you different perspectives:
- The European Database of Suspected Adverse Drug Reaction Reports is run by the European Medicines Agency. Here you can see suspected adverse reaction reports submitted by national medicines regulatory authorities and pharmaceutical companies.
- An interesting resource is the American database DrugInformer, which holds data on suspected adverse drug reactions gathered from social media (Facebook, Twitter, user review sites, forum discussions), as well as information from the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS).